Scalping Surgery â€“ Dermatologic Indications beyond Curative Primary Skin Cancer Surgery

Uwe Wollina; Dana Langner; Gesina Hansel; AndrÃ© Koch; Georgi Tchernev

doi:10.3889/oamjms.2017.115

Authors

Uwe Wollina Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden
Dana Langner Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden
Gesina Hansel Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden
AndrÃ© Koch Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden
Georgi Tchernev Department of Dermatology, Venereology and Dermatologic Surgery, Medical Institute of Ministry of Interior, and Onkoderma Policlinic for Dermatology and Dermatologic Surgery, Sofia

DOI:

https://doi.org/10.3889/oamjms.2017.115

Keywords:

Skin tumours, scalping surgery, scalp, mesh graft transplantation, dermal template

Abstract

Skin tumours are among the most frequent tumour types of mankind. In the case of large tumours, field cancerization, or satellitosis scalping surgery is a possible option. The procedure can also be used in a palliative setting with tumour debulking. Less common indications are multiple benign tumours of the scalp and chronic inflammatory scalp dermatoses not responding to medical treatment. We present a case series and discuss surgical modalities beyond curative surgery of primary skin cancer.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Desai SC, Sand JP, Sharon JD, Branham G, Nussenbaum B. Scalp reconstruction: an algorithmic approach and systematic review. JAMA Facial Plast Surg. 2015;17:56-66. https://doi.org/10.1001/jamafacial.2014.889 PMid:25375669

Wollina U, Bayyoud Y, KrÃ¶nert C, Nowak A. Giant epithelial malignancies (Basal cell carcinoma, squamous cell carcinoma): a series of 20 tumours from a single centre. J Cutan Aesthet Surg. 2012;5:12-19. https://doi.org/10.4103/0974-2077.94328 PMid:22557850 PMCid:PMC3339122

Johnson MB, Wong AK. Integra-based reconstruction of large scalp wounds: A case report and systematic review of the literature. Plast Reconstr Surg Glob Open. 2016;4:e1074. https://doi.org/10.1097/GOX.0000000000001074 PMid:27826471 PMCid:PMC5096526

Richardson MA, Lange JP, Jordan JR. Reconstruction of full-thickness scalp defects using a dermal regeneration template. JAMA Facial Plast Surg. 2016;18:62-67. https://doi.org/10.1001/jamafacial.2015.1731 PMid:26606002

Gironi LC, Boggio P, Colombo E. Reconstruction of scalp defects with exposed bone after surgical treatment of basal cell carcinoma: the use of a bilayer matrix wound dressing. Dermatol Ther. 2015;28:114-117. https://doi.org/10.1111/dth.12193 PMid:25546347

Wollina U. One-stage reconstruction of soft tissue defects with the sandwich technique: Collagen-elastin dermal template and skin graft. J Cutan Aesthet Surg. 2011;4:176-182. https://doi.org/10.4103/0974-2077.91248 PMid:22279382 PMCid:PMC3263127

Faulhaber J, Felcht M, Teerling G, Klemke CD, Wagner C, Goerdt S, Koenen W. Long-term results after reconstruction of full thickness scalp defects with a dermal regeneration template. J Eur Acad Dermatol Venereol. 2010;24:572-527. https://doi.org/10.1111/j.1468-3083.2009.03473.x PMid:19888947

Ruocco V, Ruocco E, Piccolo V, Brunetti G, Guerrera LP, Wolf R. The immunocompromised district in dermatology: A unifying pathogenic view of the regional immune dysregulation. Clin Dermatol. 2014;32:569-576. https://doi.org/10.1016/j.clindermatol.2014.04.004 PMid:25160098

Griffin LL, Lear JT. Photodynamic therapy and non-melanoma skin cancer. Cancers (Basel). 2016;8: pii: E98. https://doi.org/10.3390/cancers8100098 PMid:27782094 PMCid:PMC5082388

Edwards SL, Blessing K. Problematic pigmented lesions: approach to diagnosis. J Clin Pathol. 2000;53:409-418. https://doi.org/10.1136/jcp.53.6.409 PMCid:PMC1731214

Scolyer RA, Long GV, Thompson JF. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol Oncol. 2011;5:124-136. https://doi.org/10.1016/j.molonc.2011.03.002 PMid:21482206

Kimsey TF, Cohen T, Patel A, Busam KJ, Brady MS. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol. 2009;16:1176-1183. https://doi.org/10.1245/s10434-009-0350-7 PMid:19224283

Kaley J, Patterson JW, Chokoeva AA, Lotti T, Wollina U, Tchernev G. Are microscopic satellites in melanoma indicative of lymphovascular invasion? A preliminary case study. J Biol Regul Homeost Agents. 2015;29(1 Suppl):65-68. PMid:26016970

Austin E, Mamalis A, Ho D, Jagdeo J. Laser and light-based therapy for cutaneous and soft-tissue metastases of malignant melanoma: a systematic review. Arch Dermatol Res. 2017. https://doi.org/10.1007/s00403-017-1720-9 PMid:28314913

Boyd KU, Wehrli BM, Temple CL. Intra-lesional interleukin-2 for the treatment of in-transit melanoma. J Surg Oncol. 2011;104:711-717. https://doi.org/10.1002/jso.21968 PMid:21744347

Bottoni U, Clerico R, Paolino G, Corsetti P, Ambrifi M, Brachini A, Richetta A, NisticÃ² S, Pranteda G, Calvieri S. Melanoma and IFN alpha: potential adjuvant therapy. J Biol Regul Homeost Agents. 2014;28:271-279. PMid:25001659

Nouri N, Garbe C. Intralesional immunotherapy as a strategy to treat melanoma. Expert Opin Biol Ther. 2016;16:619-926. https://doi.org/10.1517/14712598.2016.1157161 PMid:26898656

Gorlin RJ, Goltz RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib: a syndrome. N Engl J Med. 1960;262:908â€“912. https://doi.org/10.1056/NEJM196005052621803 PMid:13851319

Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis. 2008;3:32. https://doi.org/10.1186/1750-1172-3-32 PMid:19032739 PMCid:PMC2607262

Chang AL, Arron ST, Migden MR, Solomon JA, Yoo S, Day BM, McKenna EF, Sekulic A. Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials. Orphanet J Rare Dis. 2016;11:120. https://doi.org/10.1186/s13023-016-0506-z PMid:27581207 PMCid:PMC5007799

Hansel G, Tchernev G, Chokoeva AA, Lotti T, SchÃ¶nlebe J, Wollina U. Failure of vismodegib in advanced basal cell carcinoma. J Biol Regul Homeost Agents. 2015;29(1 Suppl):11-13. PMid:26016959

Feigenbaum L, Scott BL, Moye MS, Nijhawan RI. Development of basal cell carcinoma with squamous differentiation during vismodegib treatment. Dermatol Surg. 2016.

Mohan SV, Chang J, Li S, Henry AS, Wood DJ, Chang AL. Increased risk of cutaneous squamous cell carcinoma after vismodegib therapy for basal cell carcinoma. JAMA Dermatol. 2016;152:527-532. https://doi.org/10.1001/jamadermatol.2015.4330 PMid:26914338

Liao C, Yang M, Liu P, Zhang W. A 92-year-old man with primary cutaneous diffuse large B-cell non-Hodgkin's lymphoma manifesting as a giant scalp mass: A case report. Medicine (Baltimore). 2017;96:e6270. https://doi.org/10.1097/MD.0000000000006270 PMid:28272240 PMCid:PMC5348188

Wollina U, Bayyoud Y, Kittner T, DÃ¼rig E. Giant tricholemmal squamous cell carcinoma with cranial infiltration. J Clin Aesthet Dermatol. 2011;4:34-37. PMid:21532876 PMCid:PMC3084608

Tausche AK, Richter-Huhn G, Sebastian G. Treatment of recalcitrant wounds with autologous epidermal equivalents. After excision of multiple cylindromas of the scalp. Hautarzt. 2004;55:296-300. https://doi.org/10.1007/s00105-003-0637-8 PMid:15029438

Wollina U, Gemmeke A, Koch A. Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-alpha antagonist. J Clin Aesthet Dermatol. 2012;5:36-39. PMid:22708007 PMCid:PMC3366445

MÃ¼hlstÃ¤dt M, ThomÃ© C, Kunte C. Rapid wound healing of scalp wounds devoid of periosteum with milling of the outer table and split-thickness skin grafting. Br J Dermatol. 2012;167:343-347. https://doi.org/10.1111/j.1365-2133.2012.10999.x PMid:22512740